BridgeBio Pharma, Inc. (BBIO)
76.29
-1.89
(-2.42%)
USD |
NASDAQ |
Nov 20, 15:00
BridgeBio Pharma 30-Day Average Daily Volume : 2.799M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.799M |
| November 18, 2026 | 2.839M |
| November 17, 2026 | 2.790M |
| November 16, 2026 | 2.819M |
| November 13, 2026 | 2.847M |
| November 12, 2026 | 2.897M |
| November 11, 2026 | 2.955M |
| November 10, 2026 | 2.972M |
| November 09, 2026 | 2.982M |
| November 06, 2026 | 2.981M |
| November 05, 2026 | 2.945M |
| November 04, 2026 | 2.975M |
| November 03, 2026 | 2.912M |
| November 02, 2026 | 2.956M |
| October 30, 2026 | 2.958M |
| October 29, 2026 | 2.903M |
| October 28, 2026 | 2.816M |
| October 27, 2026 | 2.872M |
| October 26, 2026 | 2.937M |
| October 23, 2026 | 2.930M |
| October 22, 2026 | 2.909M |
| October 21, 2026 | 2.918M |
| October 20, 2026 | 2.895M |
| October 19, 2026 | 2.874M |
| October 16, 2026 | 2.849M |
| Date | Value |
|---|---|
| October 15, 2026 | 2.817M |
| October 14, 2026 | 2.783M |
| October 13, 2026 | 2.741M |
| October 12, 2026 | 2.720M |
| October 09, 2026 | 2.724M |
| October 08, 2026 | 2.697M |
| October 07, 2026 | 2.642M |
| October 06, 2026 | 2.622M |
| October 05, 2026 | 2.536M |
| October 02, 2026 | 2.521M |
| October 01, 2026 | 2.501M |
| September 30, 2026 | 2.492M |
| September 29, 2026 | 2.489M |
| September 28, 2026 | 2.462M |
| September 25, 2026 | 2.466M |
| September 24, 2026 | 2.439M |
| September 23, 2026 | 2.390M |
| September 22, 2026 | 2.370M |
| September 21, 2026 | 2.342M |
| September 18, 2026 | 2.308M |
| September 17, 2026 | 2.212M |
| September 16, 2026 | 2.215M |
| September 15, 2026 | 2.112M |
| September 14, 2026 | 2.024M |
| September 11, 2026 | 2.034M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.712M |
| Ionis Pharmaceuticals, Inc. | 4.128M |
| Cytokinetics, Inc. | 1.896M |
| Pfizer Inc. | 34.09M |
| Ultragenyx Pharmaceutical, Inc. | 3.668M |